Neurol. praxi. 2010;11(6):373-377

Hyperkinetic disorders IADHD in adolescence and adulthood: diagnosis, clinical presentation and comorbidities

MUDr.Pavlína Cahová, Mgr.Jana Pejčochová, doc.MUDr.Hana Ošlejšková, Ph.D.
Klinika dětské neurologie LF MU a FN Brno

Hyperkinetic disorder (HKD) or Attention Deficit Hyperactivity Disorder (ADHD) is considered to be a neurodevelopmental disease and

also in its diagnostic criteria the onset is postulated before the age of seven. In 40–50 % of patients the symptoms persist into the adulthood.

In the case the disease is not diagnosed and tretaed properly in time, the patient is exposed to the sustained stress and pressure

and secondary somatic complaints and comorbidities may occur.

Keywords: hyperkinetic disorder, ADHD, adulthood

Published: December 31, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cahová P, Pejčochová J, Ošlejšková H. Hyperkinetic disorders IADHD in adolescence and adulthood: diagnosis, clinical presentation and comorbidities. Neurol. praxi. 2010;11(6):373-377.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T. Efficacy and safety of OROS methylphenidate in adults with attention deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol 2009; 29(3): 239-247. Go to original source... Go to PubMed...
    2. Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D. Once-daily atomoxerine for adult attention deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol 2009; 29(1): 44-50. Go to original source... Go to PubMed...
    3. Adler LA, Spencer TJ, Milton DL. Long term, open label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry 2005; 66: 294-299. Go to original source... Go to PubMed...
    4. Barkley RA. Attention-Deficit Hyperaktivity Disorder: a handbook for diagnosis and treatment. 3rd ed. New York: The Guilford Press 2006. 770p.
    5. Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 2002; 8(5): 655-672. Go to original source... Go to PubMed...
    6. Barkley RA. Drivong impairments in teens and adults with attention deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27(2): 233-260. Go to original source... Go to PubMed...
    7. Barkley RA, Murphy KR, O´Connell T, Connor DF. Effects of two doses of methylphenidate on stimulator driving performance in adults with attention deficit hyperactivity disorder. J Safety Res 2005; 36(2): 121-131. Go to original source... Go to PubMed...
    8. Barkley RA, Anderson DL, Kruesi M. A pilot study of the effects of atomoxetine on driving performance in adults with ADHD. J Atten Disord 2007; 10(3): 306-316. Go to original source... Go to PubMed...
    9. Biederman J, Faraone SV, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1996; 35(3): 343-351. Go to original source... Go to PubMed...
    10. Biederman J, Ball SW, Monuteaux MC, Mick E, Spencer TJ, McCreary M, Cote M, Faraone SV. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry 2008; 47(4): 426-434. Go to original source... Go to PubMed...
    11. Breyer JL, Botzet AM, Winters KC, Stinchfield RD, August G, Realmuto G. Young adult gambling behaviors and their relationship with the persistance of ADHD. Gambl Stud 2009; 25(2): 227-238. Go to original source... Go to PubMed...
    12. Cahová P, Pejčochová J, Ošlejšková H. Hyperkinetická porucha v klinické praxi dětského neurologa. Postgrad Med 2010; 12(1): 8-18.
    13. Cortese S, Bernardina BD, Mouren MC. Attention deficit/ hyperactivity disorder (ADHD) and binge eating. Nutr Rev 2007; 65(9): 404-411. Go to original source... Go to PubMed...
    14. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis 2000; 188(4): 230-234. Go to original source... Go to PubMed...
    15. Drtílková I, Šerý O, et al. Hyperkinetická porucha. ADHD. Praha: Galén 2007: 268.
    16. Fuemmeler BF, Kollins SH, McClernon FJ. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular-smoking from adolescence to young adulthood. J Pediatr Psychol 2007; 32(10): 1203-1213. Go to original source... Go to PubMed...
    17. Gau SS, Chiang HL. Sleep problems and disorders among adolescents with persistent and subthreshold attention-deficit/hyperactivity disorders. Sleep 2009; 32(5): 671-679. Go to original source... Go to PubMed...
    18. Gau SS, Kessler RC, Tseng WL, Wu YY, Chiu YN, Yeh CB, Hwu HG. Association between sleep problems and symptoms of attention-deficit/hyperactivity disorder in young adults. Sleep 2007; 30(2): 195-201. Go to PubMed...
    19. Goodman DW. Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management. Postgrad Med 2009; 121(5): 20-30. Go to original source... Go to PubMed...
    20. Halmoy A, Halleland H, Dramsdahl M, Bergsholm P, Fasmer OB, Haavik J. Bipolar symptoms in adult attention-deficit/hyperactivity disorder: a cross-sectional study of 510 clinically diagnosed patients and 417 population-based controls. J Clin Psychiatry 2010; 71(1): 48-57. Go to original source... Go to PubMed...
    21. Hermann B, Jones J, Dabbs K, Allen CA, Sheth R, Fine J, McMillan A, Seidenberg M. The frequency, complications snd etiology of ADHD in new onset pediatric patients.Brain 2007; 130: 3135-3148. Go to original source... Go to PubMed...
    22. Knop J, Penick EC, Nickel EJ, Mortensen EL, Sullivan MA, Murtaza S, Jensen P, Manzardo AM, Gabrielli WF. Childhood ADHD and conduct disorder as independent predictors of male alcohol dependence at age 40. Stud Alcohol Drugs 2009; 70(2): 169-177. Go to original source... Go to PubMed...
    23. Mannuzza S, Klein RG, Moulton JL. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res 2008; 160(30): 237-246. Go to original source... Go to PubMed...
    24. Merrill RM, Lyon JL, Baker RK, Gren LH. Attention deficit hyperactivity disorder and increased risk of injury. Adv Med Sci 2009; 54(1): 20-26. Go to original source... Go to PubMed...
    25. Mészáros A, Czobor P, Bálint S, Komlósi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 2009; 12(8): 1137-1147. Go to original source... Go to PubMed...
    26. Murphy K, Barkley RA. Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. Compr Psychiatry 1996; 37: 393-401. Go to original source... Go to PubMed...
    27. Ohimeier MD, Peters K, Kordon A, Seifert J, Wildt BT, Wiese B, Ziegenbein M, Emrich HM, Schneider U. Nicotine and alcohol dependence in patients with comorbid attention-deficit/ hyperactivity disorder (ADHD). Alcohol 2007; 42(6): 539-543. Go to original source... Go to PubMed...
    28. Paclt I. Diagnostika hyperkinetického syndromu v dospělosti. Pediatr. pro Praxi 2002; 3: 115-117.
    29. Rosler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, Schwitzgebel P, Pinhard K, Dovi-Akue N, Wender P, Thome J. Prevalence of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 2004; 254(6): 365-371. Go to original source... Go to PubMed...
    30. Rosler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009; 259(2): 120-129. Go to original source... Go to PubMed...
    31. Surman CB, Adamson JJ, Petty C, Biederman J, Kenealy DC, Levine M, Mick E, Faraone SV. Association between attention deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large control study. J Clin Psychiatry 2009; 70(11): 1523-1529. Go to original source... Go to PubMed...
    32. Upadhaya HP, Carpenter MJ. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addict 2008; 17(3): 195-198. Go to original source... Go to PubMed...
    33. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherpay of adults with attention deficit/hyperactivity disorder. J Atten Disord 2002; 5: 189-202. Go to original source... Go to PubMed...
    34. Yen JY, Yen CF, Chen CS, Tang TC, Ko CH. The association between adult ADHD symptoms and internet addiction among college students: the gender difference. Cyberpsychol Behav 2009; 12(2): 187-191. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.